- Advertisement -
Australia’s drugs regulator has issued a fresh warning for users of high-profile injectable diabetes and weight-loss drugs such as Ozempic.
The Therapeutic Goods Administration today updated its advice for the whole class of GLP-1 receptor agonists with warnings about the potential for suicidal…
